Presenters:
Alfredo Quinones-Hinojosa, M.D.

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Recognize the clinical severity and poor prognosis of High-Grade Gliomas (HGGs).
• Identify the urgent need for innovative therapeutic strategies beyond current standards.
• Integrate the biological complexity of HGGs and its role in treatment resistance.
• Review the evolution and current role of radiation therapy in Brain tumor Managment.
• Describe the challenges and value of translational research in developing novel treatment approaches.
• Interpret how immune modulation and radio sensitivity pathways might improve patient outcomes.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.